306 related articles for article (PubMed ID: 35565234)
1. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma.
Janowska A; Iannone M; Fidanzi C; Romanelli M; Filippi L; Del Re M; Martins M; Dini V
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565234
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
4. Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy.
Shirley CA; Chhabra G; Amiri D; Chang H; Ahmad N
Front Immunol; 2024; 15():1336023. PubMed ID: 38426087
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Innate Immune System in Cancer Dormancy and Relapse.
Chernosky NM; Tamagno I
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830776
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.
Senft D; Ronai ZA
Pigment Cell Melanoma Res; 2016 Jan; 29(1):27-42. PubMed ID: 26514653
[TBL] [Abstract][Full Text] [Related]
7. Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State.
Manjili MH
Cancer Res; 2017 May; 77(10):2564-2569. PubMed ID: 28507050
[TBL] [Abstract][Full Text] [Related]
8. Dormancy of cutaneous melanoma.
Singvogel K; Schittek B
Cancer Cell Int; 2024 Feb; 24(1):88. PubMed ID: 38419052
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease in advanced or metastatic solid cancers: The G0-G1 state and immunotherapy are key to unwinding cancer complexity.
Nicolini A; Rossi G; Ferrari P; Carpi A
Semin Cancer Biol; 2022 Feb; 79():68-82. PubMed ID: 32201368
[TBL] [Abstract][Full Text] [Related]
10. Cellular dormancy in minimal residual disease following targeted therapy.
Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
[TBL] [Abstract][Full Text] [Related]
11. Myeloid derived suppressor cells and the release of micro-metastases from dormancy.
Khadge S; Cole K; Talmadge JE
Clin Exp Metastasis; 2021 Jun; 38(3):279-293. PubMed ID: 34014424
[TBL] [Abstract][Full Text] [Related]
12. Metastatic tumor dormancy in cutaneous melanoma: does surgery induce escape?
Tseng WW; Fadaki N; Leong SP
Cancers (Basel); 2011 Feb; 3(1):730-46. PubMed ID: 24212638
[TBL] [Abstract][Full Text] [Related]
13. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications.
Robinson NJ; Parker KA; Schiemann WP
Ann Transl Med; 2020 Jul; 8(14):903. PubMed ID: 32793747
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer.
Ring A; Spataro M; Wicki A; Aceto N
Front Cell Dev Biol; 2022; 10():929893. PubMed ID: 35837334
[TBL] [Abstract][Full Text] [Related]
16. 40 years in melanoma research: an interview with Meenhard Herlyn about his career in research and the outlook for the field.
Herlyn M
Melanoma Manag; 2016 Sep; 3(3):165-169. PubMed ID: 30190885
[No Abstract] [Full Text] [Related]
17. Unveiling the role of cellular dormancy in cancer progression and recurrence.
Collignon E
Curr Opin Oncol; 2024 Mar; 36(2):74-81. PubMed ID: 38193374
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
De Angelis ML; Francescangeli F; Zeuner A
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
[TBL] [Abstract][Full Text] [Related]
19. Dormancy in breast cancer.
Banys M; Hartkopf AD; Krawczyk N; Kaiser T; Meier-Stiegen F; Fehm T; Neubauer H
Breast Cancer (Dove Med Press); 2012 Dec; 4():183-91. PubMed ID: 24367205
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Metastatic Tumor Dormancy.
Osisami M; Keller ET
J Clin Med; 2013 Sep; 2(3):136-50. PubMed ID: 26237067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
